Nectar Lifesciences Share Price
Small Cap | Pharmaceuticals and health care | NSE: NECLIFE | BSE: 532649
₹23.82 
-1.25 (-4.99 %)
Last Updated: 13 Mar 2025 12:00 AM
BEARISH
Overview
Open (₹) 23.82
High (₹) 23.82
Low (₹) 23.82
Prev. Close (₹) 25.07
Volume 44,235
VWAP (₹) 26.66
ROCE (%) 8.65
Industry P/E 43.95
TTM P/E 31.34
P/B Ratio 0.50
Market Cap (₹) Cr.533.52
Dividend Yield (%)--
EPS (₹) 0.22
ROE0.46%
Sales Growth (%) 10.53
Profit Growth (%)-120.66
Day Range
23.8223.82
52 Week Range
23.8256.39
Historical Returns
Returns (6M)
-51.27 %
Returns (1Y)
-22.61 %
Returns (3Y)
-11.94 %
Returns (5Y)
159.19 %
Returns (6M)
-51.27 %
Returns (1Y)
-22.61 %
Returns (3Y)
-11.94 %
Returns (5Y)
159.19 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
- Growth in Net Profit Margin (QoQ)
- Growth in Annual Net Profit with increasing Profit Margin (YoY)
Technicals
Technical Rating
BEARISHRSI 41.93
MFI 37.21
ATR 2.41
Commodity Channel Index -112.73
ROC125 -33.47
ROC21 -18.46
Williams %R -97.60
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 27.01 | 27.73 | 28.25 | 26.49 | 25.77 | 25.25 | 24.53 |
| Week Ago | 30.22 | 31.46 | 32.27 | 29.41 | 28.17 | 27.36 | 26.12 |
| Month Ago | 35.94 | 37.06 | 37.62 | 35.38 | 34.26 | 33.70 | 32.58 |
EMA & SMA
23.82
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 28.17
9 Day 28.54
10 Day 28.77
12 Day 29.87
14 Day 30.67
20 Day 32.22
26 Day 33.03
50 Day 36.42
100 Day 36.28
200 Day 35.76
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| SETU SECURITIES PVT. LTD. | bulk | Sell | 19 Feb, 2025 | ₹29.06 | 11,70,253 | BSE |
| MANSI SHARE & STOCK ADVISORS PRIVATE LIMITED | bulk | Sell | 23 Sept, 2024 | ₹40.98 | 16,07,989 | BSE |
| ISENGARD DIRECT PE LLC | bulk | Sell | 23 Sept, 2024 | ₹39.41 | 1,11,03,910 | BSE |
| EPITOME TRADING AND INVESTMENTS | bulk | Sell | 23 Sept, 2024 | ₹42.23 | 1,57,201 | BSE |
| MANSI SHARE & STOCK ADVISORS PRIVATE LIMITED | bulk | Buy | 23 Sept, 2024 | ₹39.38 | 16,08,007 | BSE |
| GLOBALWORTH SECURITIES LIMITED | bulk | Buy | 23 Sept, 2024 | ₹39.09 | 25,00,000 | BSE |
| EPITOME TRADING AND INVESTMENTS | bulk | Buy | 23 Sept, 2024 | ₹39.06 | 20,00,000 | BSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 19 Dec, 2024 | RAMAN GOYAL | Acquisition | ₹44.37 | 4,00,000 | BSE |
| 03 Jun, 2021 | SBICAP Trustee Company Ltd. | Pledge | ₹31.05 | 9,94,68,000 | BSE |
| 01 Jun, 2021 | Sanjiv HUF | Pledge | ₹31.05 | 4,36,22,400 | BSE |
| 01 Jun, 2021 | Sanjiv Goyal | Pledge | ₹31.05 | 5,58,45,600 | BSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 29 Jul, 2020 | Rs.0.0500 per share(5%)Final Dividend (BC dates revised) | 11 Sept, 2020 | 01 Jan, 1970 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 13 Mar, 2025 | BSE India | Update on EU regulatory inspection and Business Status |
| 13 Mar, 2025 | NSE India | Nectar Lifesciences Limited has informed the Exchange about Update on EU regulatory inspection and Business Status |
| 10 Mar, 2025 | BSE India | Update on EU regulatory inspection |
| 10 Mar, 2025 | NSE India | Nectar Lifesciences Limited has informed the Exchange about update on EU regulatory inspection |
| 28 Feb, 2025 | NSE India | NECTAR LIFESCIENCES LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
| 28 Feb, 2025 | NSE India | Nectar Lifesciences Limited has informed the Exchange regarding Cessation of as Company Secretary & Compliance Officer of the company w.e.f. February 28, 2025. |
| 28 Feb, 2025 | BSE India | Please find attached herewith as per captioned regulations. |
| 01 Feb, 2025 | NSE India | Nectar Lifesciences Limited has informed the Exchange about Copy of Newspaper Publication of Unaudited Financial Results for period ended on December 31, 2024. |
| 31 Jan, 2025 | BSE India | Investor Presentation based on Q3''25 performance |
| 31 Jan, 2025 | NSE India | Nectar Lifesciences Limited has informed the Exchange regarding ''Investor Presentation (Q3 FY25)''. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results & Others | To consider other business matters. | 27 Jan, 2025 | 31 Jan, 2025 |
| Quarterly Results | -- | 05 Nov, 2024 | 14 Nov, 2024 |
| Quarterly Results | -- | 06 Aug, 2024 | 14 Aug, 2024 |
| Audited Results | -- | 10 May, 2024 | 15 May, 2024 |
| Quarterly Results | -- | 01 Feb, 2024 | 14 Feb, 2024 |
| Quarterly Results | -- | 06 Nov, 2023 | 10 Nov, 2023 |
| Quarterly Results | -- | 09 Aug, 2023 | 14 Aug, 2023 |
| Audited Results & A.G.M. | -- | 22 May, 2023 | 26 May, 2023 |
| Quarterly Results | -- | 07 Feb, 2023 | 14 Feb, 2023 |
| Quarterly Results | -- | 09 Nov, 2022 | 14 Nov, 2022 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Nectar Lifesciences
Nectar Lifesciences is a Public Limited Listed company incorporated on 27/06/1995 and has its registered office in the State of Punjab, India. Company’s Corporate Identification Number(CIN) is L24232PB1995PLC016664 and registration number is 016664. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1684.09 Cr. and Equity Capital is Rs. 22.43 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1995
Managing Director
Mr. Sanjiv Goyal
NSE Symbol
NECLIFE
Nectar Lifesciences Management
| Name | Designation |
|---|---|
| Mr. Sanjiv Goyal | Chairman & Managing Director |
| Mr. Puneet Sud | Director - Operations |
| Dr. Indu Pal Kaur | Independent Director |
| Mr. Ajay Swaroop | Independent Director |
| Dr. Rupinder Tewari | Independent Director |
| Dr. Kuldip Kumar Bhasin | Independent Director |
| Ms. Meena Verma | Nominee Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹4,03,916.05 | ₹1,683.45  ₹1,676.85(0.39%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,49,205.29 | ₹5,620.45  ₹5,667.15(-0.82%) | ₹3,350.050 - ₹6,448.750 |
| Cipla | ₹1,18,065.23 | ₹1,461.90 ₹1,454.30(0.52%) | ₹1,317.600 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,03,430.62 | ₹3,056.05 ₹3,096.50(-1.31%) | ₹2,488.000 - ₹3,589.950 |
| Dr. Reddy's Laboratories | ₹92,453.48 | ₹1,107.95 ₹1,105.15(0.25%) | ₹1,093.000 - ₹1,420.200 |
FAQs on Nectar Lifesciences
What is the share price of Nectar Lifesciences?
The share price of Nectar Lifesciences on 13 Mar, 2025 is ₹ 23.82.
What is 52W high and 52W low share price of Nectar Lifesciences?
The highest and lowest 52W share prices of Nectar Lifesciences are ₹ 56.390 and ₹ 23.820
What is the market cap of Nectar Lifesciences?
The market capitalization of Nectar Lifesciences as of 13 Mar, 2025 is ₹ 533.52 Crores
What is the P/E ratio of Nectar Lifesciences?
The current P/E ratio of Nectar Lifesciences as of 13 Mar, 2025 is 43.95
What is the PB ratio of Nectar Lifesciences?
The PB ratio of Nectar Lifesciences as of 13 Mar, 2025 is 0.50
Top Gainers
₹41.02
₹34.29 (0.20%)
₹8.84
₹7.37 (0.20%)
₹6.97
₹5.81 (0.20%)
₹194.70
₹162.25 (0.20%)
Top Losers
₹13.75
₹135.15 (-0.90%)
₹9.60
₹12.00 (-0.20%)
₹9.80
₹93.55 (-0.90%)
₹0.99
₹4.77 (-0.79%)
Market Indices
Sensex
₹73,828.91
₹74,029.76 (0.00%)